What is Ferrous Peptonate?
Ferrous peptonate is a chelated iron compound where ferrous iron (Fe²⁺) is bound to peptide chains or amino acid complexes. This formulation is designed to improve the bioavailability and absorption of iron in the gastrointestinal tract compared to simple iron salts. The peptide chelation reduces interaction with dietary inhibitors like phytates and polyphenols that typically impair iron absorption. CAS Number 977089-87-4 identifies this specific chemical entity.
Common Uses
Ferrous peptonate is used as a nutrient fortification agent in various food and beverage products, including:
- Breakfast cereals and grain-based products
- Nutritional supplements and vitamin formulations
- Fortified beverages and juice products
- Infant and pediatric nutritional formulas
- Animal feed supplements
The iron content helps address dietary deficiencies in populations at risk for iron-deficiency anemia, including children, women of childbearing age, and individuals in developing regions. The peptonate form is preferred in some formulations because it may produce fewer gastrointestinal side effects than ferrous sulfate or ferrous fumarate.
Safety Assessment
Ferrous peptonate has not been designated as GRAS (Generally Recognized as Safe) by the FDA, indicating that it has not undergone the formal GRAS notification process. However, this classification does not indicate unsafe status—rather, it reflects the regulatory pathway taken by manufacturers.
The FDA Adverse Event Reporting System (FAERS) contains zero reported adverse events specifically linked to ferrous peptonate, and no FDA recalls have been issued for this ingredient. This suggests no significant safety signals have emerged from consumer use.
As an iron compound, ferrous peptonate shares the general toxicological profile of ferrous salts. Iron is an essential nutrient required for oxygen transport, energy metabolism, and immune function. However, excessive iron intake can cause oxidative stress and organ damage. The peptide chelation complex may influence absorption kinetics and bioavailability compared to non-chelated iron forms.
Safety considerations include:
- **Bioavailability**: The peptide complex enhances iron absorption efficiency, which may require careful dosing in fortified products
- **Iron accumulation**: Individuals with hemochromatosis or other iron metabolism disorders should limit supplemental iron intake
- **Interactions**: Iron can interact with certain medications and mineral absorption (calcium, zinc)
- **Gastrointestinal effects**: While peptonate forms are formulated to minimize side effects, constipation, nausea, and dark stools remain possible with any iron supplement
Regulatory Status
Ferrous peptonate is not explicitly listed in FDA's Food Additives Status List as GRAS. Different regulatory jurisdictions may have varying approval status. Manufacturers using this ingredient must comply with applicable food fortification regulations in their target markets.
In the European Union, iron compounds are approved as food additives and nutrients under specific regulatory frameworks (Regulation (EC) No. 1925/2006 regarding fortification). However, specific approval status for ferrous peptonate specifically should be verified with regional authorities.
Since this is a nutrient rather than a traditional food additive, it may fall under dietary supplement regulations in some jurisdictions, requiring different labeling and notification requirements.
Key Studies
Limited published peer-reviewed research exists specifically on ferrous peptonate. Most literature addresses iron bioavailability in peptide-chelated forms generally. Available evidence suggests:
- Peptide-chelated iron compounds demonstrate improved absorption compared to simple iron salts in human and animal studies
- The specific peptide composition influences bioavailability and tolerability
- Iron requirements and safety thresholds for fortified foods are well-established by FAO/WHO and FDA guidelines
Manufacturers developing ferrous peptonate formulations typically conduct bioavailability studies and safety assessments before market introduction, though these may not be publicly disclosed.